​
​

Innovid (CTV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CTV Stock Forecast

Innovid stock forecast is as follows: an average price target of $2.50 (represents a 46.20% upside from CTV’s last price of $1.71) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

CTV Price Target

The average price target for Innovid (CTV) is $2.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $2.50 to $2.50. This represents a potential 46.20% upside from CTV's last price of $1.71.

CTV Analyst Ratings

Buy

According to 4 Wall Street analysts, Innovid's rating consensus is 'Buy'. The analyst rating breakdown for CTV stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Innovid Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 23, 2024Matthew CostMorgan Stanley$2.50$2.0323.15%46.20%
Apr 16, 2024Matthew CostMorgan Stanley$2.10$2.23-5.83%22.81%
Row per page
Go to

The latest Innovid stock forecast, released on Jul 23, 2024 by Matthew Cost from Morgan Stanley, set a price target of $2.50, which represents a 23.15% increase from the stock price at the time of the forecast ($2.03), and a 46.20% increase from CTV last price ($1.71).

Innovid Price Target by Period

1M3M12M
# Anlaysts--2
Avg Price Target--$2.30
Last Closing Price$1.71$1.71$1.71
Upside/Downside-100.00%-100.00%34.50%

In the current month, the average price target of Innovid stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Innovid's last price of $1.71. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Aug 06, 2024NeedhamMarket OutperformMarket OutperformHold
Jul 23, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Jul 12, 2024NeedhamMarket OutperformMarket OutperformHold
Jun 04, 2024NeedhamMarket OutperformMarket OutperformHold
Apr 16, 2024NeedhamMarket OutperformMarket OutperformHold
Apr 16, 2024Morgan StanleyUnderperformUnderperformHold
Apr 16, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Feb 16, 2024WedbushOutperformOutperformHold
May 11, 2023OppenheimerOutperformOutperformHold
Feb 25, 2022NeedhamBuyBuyHold
Row per page
Go to

Innovid's last stock rating was published by Needham on Aug 06, 2024. The company gave CTV a "Market Outperform" rating, the same as its previous rate.

Innovid Financial Forecast

Innovid Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
Revenue--------$38.62M$36.23M-$30.48M$33.70M$34.47M$33.09M$25.86M$25.97M
Avg Forecast$43.85M$42.65M$40.75M$38.95M$38.80M$40.80M$38.50M$35.15M$36.20M$35.47M$32.00M$29.53M$35.47M$34.47M$33.50M$21.27M$27.05M
High Forecast$44.31M$43.10M$41.18M$39.36M$39.21M$41.23M$38.91M$35.52M$36.58M$35.47M$32.34M$29.85M$35.84M$34.47M$33.50M$21.27M$27.05M
Low Forecast$43.39M$42.20M$40.32M$38.54M$38.39M$40.37M$38.09M$34.78M$35.82M$35.47M$31.66M$29.22M$35.09M$34.47M$33.50M$21.27M$27.05M
# Analysts11111111211111111
Surprise %--------1.07%1.02%-1.03%0.95%1.00%0.99%1.22%0.96%

Innovid's average Quarter revenue forecast for Mar 24 based on 1 analysts is $35.15M, with a low forecast of $34.78M, and a high forecast of $35.52M. CTV's average Quarter revenue forecast represents a -8.98% decrease compared to the company's last Quarter revenue of $38.62M (Dec 23).

Innovid EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts11111111211111111
EBITDA--------$1.64M$5.11M-$-6.18M$-2.08M$-4.15M$-8.25M$-9.12M$-6.53M
Avg Forecast$-3.11M$-3.03M$-2.89M$-2.76M$-2.75M$-2.90M$-2.73M$-2.49M$-2.57M$-2.52M$-2.27M$-2.10M$-2.52M$-2.45M$-2.38M$-3.60M$-334.89M
High Forecast$-3.08M$-2.99M$-2.86M$-2.73M$-2.72M$-2.86M$-2.70M$-2.47M$-2.54M$-2.52M$-2.25M$-2.07M$-2.49M$-2.45M$-2.38M$-2.88M$-267.91M
Low Forecast$-3.14M$-3.06M$-2.92M$-2.79M$-2.78M$-2.93M$-2.76M$-2.52M$-2.60M$-2.52M$-2.30M$-2.12M$-2.54M$-2.45M$-2.38M$-4.32M$-401.86M
Surprise %---------0.64%-2.03%-2.95%0.83%1.70%3.47%2.53%0.02%

1 analysts predict CTV's average Quarter EBITDA for Mar 24 to be $-2.49M, with a high of $-2.47M and a low of $-2.52M. This is -252.20% lower than Innovid's previous annual EBITDA (Dec 23) of $1.64M.

Innovid Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts11111111211111111
Net Income--------$-1.66M$-2.73M-$-8.56M$-3.43M$-11.83M$4.30M$-7.45M$-7.62M
Avg Forecast$4.58M$1.53M$-4.58M$-762.52K$508.30K$-508.30K$-2.03M$-3.05M$-1.02M$-2.03M$-4.58M$-7.12M$-3.05M$-6.76M$-5.79M$-5.96M$-390.80M
High Forecast$4.64M$1.55M$-4.51M$-752.02K$515.29K$-501.30K$-2.01M$-3.01M$-1.00M$-2.01M$-4.51M$-7.02M$-3.01M$-6.76M$-5.79M$-4.77M$-312.64M
Low Forecast$4.51M$1.50M$-4.64M$-773.02K$501.30K$-515.29K$-2.06M$-3.09M$-1.03M$-2.06M$-4.64M$-7.21M$-3.09M$-6.76M$-5.79M$-7.15M$-468.96M
Surprise %--------1.63%1.34%-1.20%1.12%1.75%-0.74%1.25%0.02%

Innovid's average Quarter net income forecast for Sep 22 is $-6.76M, with a range of $-6.76M to $-6.76M. CTV's average Quarter net income forecast represents a -257.12% decrease compared to the company's last Quarter net income of $4.30M (Jun 22).

Innovid SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts11111111211111111
SG&A--------$22.06M$20.93M-$21.29M$20.56M$22.77M$24.27M$21.99M$19.61M
Avg Forecast$27.18M$26.44M$25.26M$24.14M$24.05M$25.29M$23.86M$21.79M$22.44M$21.98M$19.84M$18.31M$21.98M$21.36M$20.77M$17.59M$16.77M
High Forecast$27.47M$26.72M$25.53M$24.40M$24.31M$25.56M$24.12M$22.02M$22.68M$21.98M$20.05M$18.50M$22.22M$21.36M$20.77M$21.11M$16.77M
Low Forecast$26.89M$26.16M$24.99M$23.89M$23.80M$25.02M$23.61M$21.56M$22.20M$21.98M$19.63M$18.11M$21.75M$21.36M$20.77M$14.07M$16.77M
Surprise %--------0.98%0.95%-1.16%0.94%1.07%1.17%1.25%1.17%

Innovid's average Quarter SG&A projection for Mar 24 is $21.79M, based on 1 Wall Street analysts, with a range of $21.56M to $22.02M. The forecast indicates a -1.22% fall compared to CTV last annual SG&A of $22.06M (Dec 23).

Innovid EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts11111111211111111
EPS--------$-0.01$-0.02-$-0.06$-0.03$-0.09$0.03$-0.06$-0.14
Avg Forecast$0.03$0.01$-0.03$-0.01-$-0.00$-0.01$-0.02$-0.01$-0.01$-0.03$-0.05$-0.02$-0.05$-0.04$-0.05$-0.01
High Forecast$0.03$0.01$-0.03$-0.00-$-0.00$-0.01$-0.02$-0.01$-0.01$-0.03$-0.05$-0.02$-0.05$-0.04$-0.05$-0.01
Low Forecast$0.03$0.01$-0.03$-0.01-$-0.00$-0.01$-0.02$-0.01$-0.01$-0.03$-0.05$-0.02$-0.05$-0.04$-0.05$-0.01
Surprise %--------1.77%1.50%-1.35%1.28%1.91%-0.75%1.20%10.50%

According to 1 Wall Street analysts, Innovid's projected average Quarter EPS for Sep 22 is $-0.05, with a low estimate of $-0.05 and a high estimate of $-0.05. This represents a -255.56% decrease compared to CTV previous annual EPS of $0.03 (Jun 22).

Innovid Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ADCTADC Therapeutics SA$2.06$9.33352.91%Buy
CMTLComtech Telecommunications$2.93$9.00207.17%Hold
ADTNADTRAN$7.92$17.00114.65%Buy
CTVInnovid$1.71$2.5046.20%Buy
BDCBelden$118.68$134.0012.91%Buy

CTV Forecast FAQ

Is Innovid a good buy?

Yes, according to 4 Wall Street analysts, Innovid (CTV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of CTV's total ratings.

What is CTV's price target?

Innovid (CTV) average price target is $2.5 with a range of $2.5 to $2.5, implying a 46.20% from its last price of $1.71. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Innovid stock go up soon?

According to Wall Street analysts' prediction for CTV stock, the company can go up by 46.20% (from the last price of $1.71 to the average price target of $2.5), up by 46.20% based on the highest stock price target, and up by 46.20% based on the lowest stock price target.

Can Innovid stock reach $3?

CTV's average twelve months analyst stock price target of $2.5 does not support the claim that Innovid can reach $3 in the near future.

What are Innovid's analysts' financial forecasts?

Innovid's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $153.25M (high $154.87M, low $151.63M), average EBITDA is $-10.876M (high $-10.761M, low $-10.991M), average net income is $-5.083M (high $-4.999M, low $-5.167M), average SG&A $94.99M (high $96M, low $93.99M), and average EPS is $-0.0333 (high $-0.0328, low $-0.0339). CTV's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $166.2M (high $167.96M, low $164.44M), average EBITDA is $-11.795M (high $-11.67M, low $-11.92M), average net income is $762.52K (high $919.98K, low $605.06K), average SG&A $103.02M (high $104.11M, low $101.93M), and average EPS is $0.005 (high $0.00603, low $0.00397).

Did the CTV's actual financial results beat the analysts' financial forecasts?

Based on Innovid's last annual report (Dec 2023), the company's revenue was $139.88M, beating the average analysts forecast of $133.2M by 5.02%. Apple's EBITDA was $-5.458M, missing the average prediction of $-9.453M by -42.26%. The company's net income was $-31.911M, beating the average estimation of $-14.742M by 116.46%. Apple's SG&A was $84.66M, beating the average forecast of $82.57M by 2.53%. Lastly, the company's EPS was $-0.23, beating the average prediction of $-0.0967 by 137.93%. In terms of the last quarterly report (Dec 2023), Innovid's revenue was $38.62M, beating the average analysts' forecast of $36.2M by 6.68%. The company's EBITDA was $1.64M, missing the average prediction of $-2.569M by -163.80%. Innovid's net income was $-1.658M, beating the average estimation of $-1.017M by 63.07%. The company's SG&A was $22.06M, missing the average forecast of $22.44M by -1.70%. Lastly, the company's EPS was $-0.0118, beating the average prediction of $-0.00667 by 76.99%